Charles River Laboratories International, Inc.
CRL · Healthcare · Life Sciences Tools & Services
Updated 6h ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #395 of 500 by Iconic Score · #50 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Charles River Laboratories International Inc (CRL) is a leading provider of essential services and products to the pharmaceutical and biotechnology sectors, specializing in preclinical and clinical laboratory services. With a market capitalization of $10.5 billion, CRL plays a crucial role in the drug development process, offering a comprehensive range of solutions including research models, laboratory services, and regulatory consulting. The company is well-positioned in the Life Sciences Tools & Services sector, benefiting from the growing demand for innovative therapies and the increasing complexity of drug development. CRL's expertise and extensive portfolio enable it to support clients in accelerating their research and development efforts, thereby contributing to advancements in healthcare and improving patient outcomes. Its strategic focus on quality and compliance further solidifies its reputation as a trusted partner in the life sciences industry.
IconicOracleAI™ Brief
Charles River Laboratories International Inc (CRL) currently holds an Iconic Score of 42, reflecting moderate brand recognition and sentiment. The recent 8.24% price increase is likely influenced by positive momentum in the healthcare sector, as highlighted by industry trends and the growing demand for clinical trial management services. Additionally, strong brand visibility, indicated by a score of 75/100 from logo analysis, suggests that CRL is gaining attention amidst a competitive landscape, particularly as drugmakers increasingly outsource clinical trial management.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.